Get started
Author

Shaofei Zhang

Observed names: S. Zhang, Zhang Shaofei, Zhang, Shaofei
ORCID: 0000-0002-8377-2270
Observed ORCID: 0000-0002-8377-2270
OpenAlex ID: A5084317268
Omentin-1: a newly discovered warrior against metabolic related diseases
2022 · Aizhen Zhao, Haoxiang Xiao, et al. · Expert Opinion on Therapeutic Targets · 87
The NLRP3 inflammasome in fibrosis and aging: The known unknowns
2022 · Yanqing Liu, Xuezeng Xu, et al. · Ageing Research Reviews · 65
Lycorine and organ protection: Review of its potential effects and molecular mechanisms
2022 · Haoxiang Xiao, Xuezeng Xu, et al. · Phytomedicine · 53
Novel role of COX6c in the regulation of oxidative phosphorylation and diseases
2022 · Changyu Wang, Jianjun Lv, et al. · Cell Death Discovery · 50
PDF
Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity
2021 · Zhenxing Liang, Ying Chen, et al. · Journal of Advanced Research · 40
PDF
Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway
2022 · Meng Sun, Huadong Zhao, et al. · Free Radical Biology and Medicine · 31
Neuroprotective Effects of Omentin-1 Against Cerebral Hypoxia/Reoxygenation Injury via Activating GAS6/Axl Signaling Pathway in Neuroblastoma Cells
2022 · Xiaochen Niu, Ye Cheng, et al. · Frontiers in Cell and Developmental Biology · 29
Protection of melatonin treatment and combination with traditional antibiotics against septic myocardial injury
2023 · Wencheng Di, Zhenxiao Jin, et al. · Cellular & Molecular Biology Letters · 28
PDF
A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment
2020 · Zhihui Kuang, Pu Pu, et al. · Molecular Cancer Therapeutics · 26
PDF
Protection of zero-valent iron nanoparticles against sepsis and septic heart failure
2022 · Daquan Wang, Changyu Wang, et al. · Journal of Nanobiotechnology · 25
PDF
Identification of PIK3CG as a hub in septic myocardial injury using network pharmacology and weighted gene co‐expression network analysis
2022 · Qiong Liu, Yushu Dong, et al. · Bioengineering & Translational Medicine · 21
Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6 /Axl signaling
2022 · Wangrui Lei, Songdi Wu, et al. · Phytotherapy Research · 20
Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome
2023 · Chao Deng, Qiong Liu, et al. · Bioengineering & Translational Medicine · 19
PDF
Activation of NR1H3 signaling pathways by psoralidin attenuates septic myocardial injury
2023 · Yang Yang, Wangrui Lei, et al. · Free Radical Biology and Medicine · 18
PDF
Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers
2025 · Yang Yang, Luyang Du, et al. · Medicinal Research Reviews · 11
Association of Helicobacter pylori infection and white blood cell count: a cross-sectional study
2024 · Rui Jiao, Xiaojuan Ma, et al. · BMJ Open · 11
PDF
Sulfide-modified nanoscale zero-valent iron as a novel therapeutic remedy for septic myocardial injury
2023 · Daquan Wang, Huadong Zhao, et al. · Journal of Advanced Research · 9
Case report: Modified transplantation for pediatric patients with pyruvate kinase deficiency
2024 · Yuhui Pang, Xiaoyu Qi, et al. · Frontiers in Immunology · 4
PDF
OA14.05 KRAS G12C Inhibitor IBI351 In Patients (pts) with Advanced Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Pivotal Phase 2 Study
2024 · Q. Zhou, X. Meng, et al. · Journal of Thoracic Oncology · 3
PDF
1989P Efficacy and safety of fulzerasib in patients (pts) with KRAS G12C-mutant non-small cell lung cancer (NSCLC): Updated results from phase I/II studies
2025 · Y-L. Wu, Q. Zhou, et al. · Annals of Oncology · 2
Gold-Catalyzed Intermolecular Carboalkoxylation of Alkenes
2012 · Xiangdong Hu, Wenmin Dong, et al. · Synlett · 2
Eosinophil Recovery Time Is Associated with Clinical Outcomes in Patients with Type A Acute Aortic Dissection: a Retrospective Cohort Study
2024 · Xue Wang, Yanli Zhu, et al. · Journal of Cardiovascular Translational Research · 1
Supplementary Figure 3 from A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment
2023 · Zhihui Kuang, Pu Pu, et al.
Supplementary Figure 5 from A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment
2023 · Zhihui Kuang, Pu Pu, et al.
supplementary Figure 1 from A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment
2023 · Zhihui Kuang, Pu Pu, et al.
Works count: 41
Citation count: 555
H-index: 14
I10-index: 16
Year
Topic
Type